- Email: [email protected]
Fourth world congress on vaccines and immunisation
Vaccine 22 (2003) 545–546
First Announcement and Call for Participation
Fourth World Congress on Vaccines and Immunisation 30 September–3 October 2004, Tsukuba Science City, Tokyo, Japan WCVI 2004 Japan
The World Congress on Vaccines and Immunisation is the unique congress to discuss all aspects concerning the development of new vaccines and immunisation strategies to prevent and control infections as well as other diseases of importance in human and veterinary medicine. Several plenary sessions, symposia, workshops and daily posters will give an opportunity for information exchange and co-operation to all colleagues from Academia, Industry, Governmental Services, Hospitals, Research Institutes and International Health Organisations who are interested to promote the science, research and expertise in vaccinology. Tsukuba Science City is located in parks and gardens, near Tokyo (50 km) and Narita International Airport (40 km) with a modern international convention centre and large choice of deluxe hotels reserved at special prices. Tsukuba is the most advanced academic community and the largest R&D center in Japan with a cosmopolitan flavor as 6500 foreign researchers from 120 countries are working in this blessed natural environment of hills and lakes. Tsukuba is the home of 300 national, public and private research institutes and universities as well as of traditional cultural activities and tourism. Our colleagues from all continents are cordially invited by Prof. Dr. Edouard Kurstak, founder and president of the Congress and by the Japan National Host Committee (JNHC) to attend this very important and unique scientific and medical forum. The WCVI 2004 is organised by the Infections Control World Organization (ICWO), scheduled under the auspices of the Ministry of Health, Ministry of Education and Sciences of Japan with co-operation of the Japan National Host Committee (Dr. Tetsuo Nakayama, Dr. Hitoshi Kamiya, Dr. Nobuhiko Okabe, Dr. Masato Tashiro, Dr. Tatsuo Katou) and involvement of the National Institute of Infectious Diseases, Faculty of Medicine of University of Montreal, Japanese Society for Vaccinology, Japanese Society for Pediatric Infectious Diseases, Japanese Society for Clinical Virology, 0264-410X/$ – see front matter doi:10.1016/j.vaccine.2003.11.010
Japanese Society for Infectious Diseases, Japanese Society for Veterinary Medicine, International Society for Vaccines, Sociedad Iberoamericana de Informacion Cientifica and Vaccine Elsevier. For information regarding lectures, exhibition stands, hotel accommodation, registration please contact: Edouard Kurstak, Congress & ICWO President, Faculty of Medicine, University of Montreal, Montreal, Canada. E-mail: [email protected] and URL: http://www3.sympatico.ca/kurstak/icwo WCVI 2004 will focus mainly on: • Development of new vaccines, immunisation concepts and strategies • New trends in combination vaccines and immunisation • Paediatric vaccines and childhood immunisation • Practical issues, social aspects and safety of current vaccination • Barriers to developing and introducing new vaccines— biotechs challenges • Future challenges in vaccines safety and regulatory issues • Vaccines novel vectors, delivery systems and immunopotentiators • Progress in mucosal vaccines and immunisation • Advances in gene-bases vaccines • Progress in vaccine immunotherapy • Peptides and mimotopes vaccines strategies • Transcutaneous vaccines • Anti-cancer vaccines and disease therapeutic vaccination • Genomics for vaccines research • New technologies for vaccines development and quality control • Plant-based systems for vaccines and pharmaceuticals
546
/ Vaccine 22 (2003) 545–546
• Progress in immunisation programmes to eliminate infections: polio and measles • Viral hepatitis and AIDS prevention and global control • Advances in vaccines against meningitis • Progress in vaccines against pneumococcal infections • Progress in vaccines for enteric pathogen infections • Vaccines for parasitic and chlamydia diseases • Vaccines and immunisation against respiratory infections • Current status in human immunodeficiency virus vaccines research and clinical trials
• Progress in research for improved vaccines against tuberculosis • Development of new bacterial and viral vaccines • Rabies vaccination and immunotherapy • Vaccine approach in tissue and organ transplantation • New horizon of co-operation with Global Alliance for Vaccines and Immunisation/The Vaccine Fund Well known and high profile experts will present lectures on latest research and clinical achievements.
First Announcement and Call for Participation
Fourth World Congress on Vaccines and Immunisation 30 September–3 October 2004, Tsukuba Science City, Tokyo, Japan WCVI 2004 Japan
The World Congress on Vaccines and Immunisation is the unique congress to discuss all aspects concerning the development of new vaccines and immunisation strategies to prevent and control infections as well as other diseases of importance in human and veterinary medicine. Several plenary sessions, symposia, workshops and daily posters will give an opportunity for information exchange and co-operation to all colleagues from Academia, Industry, Governmental Services, Hospitals, Research Institutes and International Health Organisations who are interested to promote the science, research and expertise in vaccinology. Tsukuba Science City is located in parks and gardens, near Tokyo (50 km) and Narita International Airport (40 km) with a modern international convention centre and large choice of deluxe hotels reserved at special prices. Tsukuba is the most advanced academic community and the largest R&D center in Japan with a cosmopolitan flavor as 6500 foreign researchers from 120 countries are working in this blessed natural environment of hills and lakes. Tsukuba is the home of 300 national, public and private research institutes and universities as well as of traditional cultural activities and tourism. Our colleagues from all continents are cordially invited by Prof. Dr. Edouard Kurstak, founder and president of the Congress and by the Japan National Host Committee (JNHC) to attend this very important and unique scientific and medical forum. The WCVI 2004 is organised by the Infections Control World Organization (ICWO), scheduled under the auspices of the Ministry of Health, Ministry of Education and Sciences of Japan with co-operation of the Japan National Host Committee (Dr. Tetsuo Nakayama, Dr. Hitoshi Kamiya, Dr. Nobuhiko Okabe, Dr. Masato Tashiro, Dr. Tatsuo Katou) and involvement of the National Institute of Infectious Diseases, Faculty of Medicine of University of Montreal, Japanese Society for Vaccinology, Japanese Society for Pediatric Infectious Diseases, Japanese Society for Clinical Virology, 0264-410X/$ – see front matter doi:10.1016/j.vaccine.2003.11.010
Japanese Society for Infectious Diseases, Japanese Society for Veterinary Medicine, International Society for Vaccines, Sociedad Iberoamericana de Informacion Cientifica and Vaccine Elsevier. For information regarding lectures, exhibition stands, hotel accommodation, registration please contact: Edouard Kurstak, Congress & ICWO President, Faculty of Medicine, University of Montreal, Montreal, Canada. E-mail: [email protected] and URL: http://www3.sympatico.ca/kurstak/icwo WCVI 2004 will focus mainly on: • Development of new vaccines, immunisation concepts and strategies • New trends in combination vaccines and immunisation • Paediatric vaccines and childhood immunisation • Practical issues, social aspects and safety of current vaccination • Barriers to developing and introducing new vaccines— biotechs challenges • Future challenges in vaccines safety and regulatory issues • Vaccines novel vectors, delivery systems and immunopotentiators • Progress in mucosal vaccines and immunisation • Advances in gene-bases vaccines • Progress in vaccine immunotherapy • Peptides and mimotopes vaccines strategies • Transcutaneous vaccines • Anti-cancer vaccines and disease therapeutic vaccination • Genomics for vaccines research • New technologies for vaccines development and quality control • Plant-based systems for vaccines and pharmaceuticals
546
/ Vaccine 22 (2003) 545–546
• Progress in immunisation programmes to eliminate infections: polio and measles • Viral hepatitis and AIDS prevention and global control • Advances in vaccines against meningitis • Progress in vaccines against pneumococcal infections • Progress in vaccines for enteric pathogen infections • Vaccines for parasitic and chlamydia diseases • Vaccines and immunisation against respiratory infections • Current status in human immunodeficiency virus vaccines research and clinical trials
• Progress in research for improved vaccines against tuberculosis • Development of new bacterial and viral vaccines • Rabies vaccination and immunotherapy • Vaccine approach in tissue and organ transplantation • New horizon of co-operation with Global Alliance for Vaccines and Immunisation/The Vaccine Fund Well known and high profile experts will present lectures on latest research and clinical achievements.